• Complex
  • Title
  • Keyword
  • Abstract
  • Scholars
  • Journal
  • ISSN
  • Conference
成果搜索

author:

Chen, Feng (Chen, Feng.) [1] | He, Lei (He, Lei.) [2] | Qiu, Liman (Qiu, Liman.) [3] | Zhou, Yang (Zhou, Yang.) [4] | Li, Zhenli (Li, Zhenli.) [5] | Chen, Geng (Chen, Geng.) [6] | Xin, Fuli (Xin, Fuli.) [7] | Dong, Xiuqing (Dong, Xiuqing.) [8] | Xu, Haipo (Xu, Haipo.) [9] | Wang, Gaoxiong (Wang, Gaoxiong.) [10] | Liu, Jingfeng (Liu, Jingfeng.) [11] | Cai, Zhixiong (Cai, Zhixiong.) [12]

Indexed by:

SCIE

Abstract:

Background: Circular RNAs (circRNAs) could interact with miRNAs to regulate gene expression, participating in hepatocellular carcinoma (HCC) initiation and development. This work aimed to determine the potential function and molecular mechanism of circEPB41L2 (hsa_circ_0077837) during HCC progression. Materials and Methods: The expression of circEPB41L2 in HCC tissues and HCC cell lines was quantified using real-time quantitative PCR (qRT-PCR). CCK-8 assays and colony formation assays were utilized to detect the proliferation of HCC cells. Wound healing assay and transwell assay were performed to determine the capability of migration and invasion for HCC cells. Western blot was conducted to determine gene expression on protein levels. The effect of circEPB41L2 on HCC in vivo was investigated via xenograft experiment. Interaction between circEPB41L2 and miR-590-5p was predicted through bioinformatics methods and confirmed via luciferase reporter assay. Results: Extensive analysis of circRNA profiles in tumor and matched para-tumor tissues collected from 61 HCC patients identified that circEPB41L2 was significantly downregulated in HCC, which was further confirmed in another HCC group by qRT-PCR analysis. The clinicopathological analysis revealed that down-regulation of circEPB41L2 was negatively associated with tumor size, vascular invasion and alpha-fetoprotein, while positively correlated with HCC prognosis. The biological function experiments showed that overexpression of circEPB41L2 could obviously inhibit the proliferation and metastasis of HCC cells in vitro, while knockdown of circEPB41L2 induced opposite results. Moreover, we also found that circEPB41L2 inhibited HCC migration and invasion though EMT signaling pathway. Similarly, overexpression of circEPB41L2 can also significantly inhibit the proliferation of HCC cells in vivo. Bioinformatic analysis and luciferase reporter assay revealed that circEPB41L2 interacts directly with miR-590-5p and the corresponding biological functions were also verified in miRNA rescue experiments. Conclusion: Our results suggest that circEPB41L2 might function as a tumor suppressor during HCC progression by sponging miR-590-5p.

Keyword:

circEPB41L2 circular RNA hepatocellular carcinoma miR-590-5p

Community:

  • [ 1 ] [Chen, Feng]Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou 350002, Peoples R China
  • [ 2 ] [Chen, Feng]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China
  • [ 3 ] [He, Lei]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China
  • [ 4 ] [Qiu, Liman]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China
  • [ 5 ] [Zhou, Yang]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China
  • [ 6 ] [Li, Zhenli]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China
  • [ 7 ] [Chen, Geng]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China
  • [ 8 ] [Xin, Fuli]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China
  • [ 9 ] [Dong, Xiuqing]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China
  • [ 10 ] [Xu, Haipo]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China
  • [ 11 ] [Liu, Jingfeng]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China
  • [ 12 ] [Cai, Zhixiong]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China
  • [ 13 ] [He, Lei]Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350025, Peoples R China
  • [ 14 ] [Qiu, Liman]Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350025, Peoples R China
  • [ 15 ] [Zhou, Yang]Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350025, Peoples R China
  • [ 16 ] [Li, Zhenli]Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350025, Peoples R China
  • [ 17 ] [Chen, Geng]Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350025, Peoples R China
  • [ 18 ] [Xin, Fuli]Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350025, Peoples R China
  • [ 19 ] [Dong, Xiuqing]Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350025, Peoples R China
  • [ 20 ] [Xu, Haipo]Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350025, Peoples R China
  • [ 21 ] [Liu, Jingfeng]Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350025, Peoples R China
  • [ 22 ] [Cai, Zhixiong]Fuzhou Univ, Mengchao Med X Ctr, Fuzhou 350025, Peoples R China
  • [ 23 ] [Wang, Gaoxiong]Fujian Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 2, Zhongshan North Rd 34, Quanzhou 362001, Peoples R China

Reprint 's Address:

  • 蔡志雄

    [Cai, Zhixiong]Fujian Med Univ, United Innovat Mengchao Hepatobiliary Technol Key, Mengchao Hepatobiliary Hosp, Xihong Rd 312, Fuzhou 350025, Fujian, Peoples R China;;[Wang, Gaoxiong]Fujian Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 2, Zhongshan North Rd 34, Quanzhou 362001, Peoples R China

Show more details

Related Keywords:

Source :

CANCER MANAGEMENT AND RESEARCH

ISSN: 1179-1322

Year: 2021

Volume: 13

Page: 2969-2981

3 . 6 0 2

JCR@2021

2 . 5 0 0

JCR@2023

ESI Discipline: CLINICAL MEDICINE;

ESI HC Threshold:90

JCR Journal Grade:3

CAS Journal Grade:4

Cited Count:

WoS CC Cited Count:

SCOPUS Cited Count:

ESI Highly Cited Papers on the List: 0 Unfold All

WanFang Cited Count:

Chinese Cited Count:

30 Days PV: 1

Online/Total:188/10033157
Address:FZU Library(No.2 Xuyuan Road, Fuzhou, Fujian, PRC Post Code:350116) Contact Us:0591-22865326
Copyright:FZU Library Technical Support:Beijing Aegean Software Co., Ltd. 闽ICP备05005463号-1